Scientists from the University of Missouri have developed a microfluidic chip and high-conductivity agarose gel that could enable a highly sensitive, portable, and reusable nucleic acid testing device for point-of-care and field applications.

Having recently secured a key US patent covering the device, MU's Office of Technology Management and Industry Relations is now offering the technology for license, claiming it has broad applicability in the medical, agricultural, veterinary, and environmental testing markets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.